About IJO Press


B. Brief Introduction on IJO Press

International Journal of Ophthalmology Press (IJO Press) is the only ophthalmological professional journal publisher in the world. It was founded by an eminent ophthalmologist—Prof. Xiu-Wen Hu in 2003, Xi’an, China, and approved by the Chinese government. Now we are publishing three academic periodicals in Ophthalmology: IJO, IES, and IER. 

1. International Journal of Ophthalmology—IJO (English edition, ISSN:2222-3959) is a global ophthalmological scientific publication indexed in SCIE, PubMed, PMC, CA, Scopus, EMBASE, IC etc., and also selected as 2019' The Highest International Impact Academic Journal of China. Its JCR IF in 2019 is 1.33, CiteScore 2019 is 2.1, monthly.

2. International Eye Science—IES (Guoji  Yanke Zazhi, ISSN:1672-5123) is a Chinese-English-mixed Ophthalmological publication indexed in Scopus, EMBASE, CA, IC, DOAJ, WPRIM of WHO, Chinese Core Journals, and China Core Periodical of Science and Technology. Its CST JCR IF in 2019 is 1.628, monthly.

3. International Eye Research— IER (English edition, ISSN:2664-7478) is the IJO’s new sister journal and a peer-reviewed open access periodical. It started in March 2020, quarterly.

IJO Press is the cooperative institution of ICO, AACO, APAO, AAO, COS, NLM and Clarivate etc. And it is also the teaching base of Xi’an Medical University and Xinxiang Medical University. IJO Press obtains guidance and support from ICO, AACO, APAO and others. Our authors, reviewers and readers are all over the world.

 

IJO Press

Add.: Wanda Plaza, No.8 Yanta North Road, Xi’an 710054, P. R. China

Web: www.ijo.cn; E-mail: ijopress@163.com; ijo2000@126.com

Tel: +8629-82210956/85569828

C. Major members of scientific quality team 

General Scientific Advisors 
Prof. Peter Wideamann (President of International Council of Ophthalmology-ICO),

Prof. Hugh Taylor (Immediate Past President of ICO),

Prof. Bruce Spivey (Past President of ICO),

and Prof. Daiming Fan (Academician and Vice President, Chinese Academy of Engineering).

Honorary Editors-in-Chief 
Prof. Mark Tso (Ex-vice President of ICO), Prof. Le Zhen Wu, President of AACO,

Prof. Li-Xin Xie (Academician of Chinese Academy of Engineering/Honorary President of Chinese Ophthalmological Society).
Chief Editor Prof. Xiu-Wen Hu (President of IJO Press). 
Editors-in-Chief  Prof. Yan-Nian Hui (Ex-Director, Eye Institute of the Whole Army, the Fourth Military Medical University of Chinese PLA).

and Prof. George Chiou (Founding chief editor of Journal of Ocular Pharmacology & Therapeutics). 
Associate Editors

Prof. Ning-Li Wang (President of APAO), Prof. Ke Yao (President of Chinese Ophthalmological Society), Prof. Yu-Sheng Wang (Director, Eye Institute of Chinese PLA) and Prof. William Smiddy (Bascom Palmer Eye Institute) et al.

International Scientific Advisors 

Prof. Clement C. Y. Tham (ICO Treasurer, CEO of APAO), Prof. Chi-Chao Chan (National Eye Institute, USA) and Prof. Richard L Abbott (Ex-President of AAO/PAAO) et al
Major members of the management team
President/Chief Editor Prof. Xiu-Wen Hu (Owners of IJO Press, Xi’an, China). 
Editors-in-Chief Prof. Yan-Nian Hui (Ex-Director, Eye Institute of the Whole Army, the Fourth Military Medical University of Chinese PLA, Xi’an, China) 
Associate Editor-in Chief Prof. Yu-Sheng Wang (Director, Eye Institute of the Whole Army, the Fourth Military Medical University of Chinese PLA, Xi’an, China) 
Managing Director Ms. Xinyue Hu (IJO Press, Xi’an, China) 
Editorial Director Ms. Juan Peng (IES Editorial Office, Xi’an, China) 

                      Ms. Yingna Wang (IJO Editorial Office)

Publication credentials

Prof. Xiu-Wen Hu, President/Chief Editor is the founder of three academic publications, International Journal of Ophthalmology (IJO), International Eye Science (IES/Guoji Yanke Zazhi), and International Eye Research (IER), with rich experience in scholarly and life science publishing.  IJO has been indexed in SCI-Expanded, PubMed, PubMed-Central, Chemical Abstracts, Scopus, EMBASE, DOAJ and selected as 2019' The Highest International Impact Academic Journal of China. Its IF in JCR 2019 is 1.33. IES (Guoji  Yanke Zazhi) is a Chinese-English-mixed ophthalmological publication and has been indexed in Scopus, EMBASE, CA, IC, DOAJ, Chinese Core Journal and China Core Periodical of Science and Technology.


Prof. Yan-Nian Hui, Editor-in-Chief of IJO and IES is the Chief Editor of the national selection teaching material “Ophthalmology”, and the Associate Editors-in-Chief of the Medical Encyclopedia of China. He is also the ex Associate Editor-in-Chief of Chinese Journal of Ophthalmology (indexed in MEDLINE), and published more than 200 papers and 12 monographs with extensive experience in scholarly and life science publishing.


Editorial Policy

 Peer Review

 All manuscripts are subjected to double blind peer-review and editorial approval before accepting for publication. All contributions will be sent to at least three or more independent reviewers, selected by the editors. Authors are welcome to suggest suitable independent reviewers and may also request that the journal excludes one or two individuals or laboratories, but the editor's decision on the choice of referees is final. Editors, authors and reviewers are required to keep confidential all details of the editorial and peer-review process on submitted manuscripts, the peer-review process is confidential and conducted anonymously. Outcomes of the review process include acceptance, acceptance with revisions but without re-review, revise and resubmit, or rejection. Results of the review process are normally available in 3 months of submission.

 

Ethical Approval of Studies and Informed Consent

For all manuscripts reporting data from studies involving human participants or animals, a formal review and approval, or formal review and waiver by an appropriate institutional review board or ethics committee is required, and should be described in the Subjects and Methods section. For investigators who do not have a formal ethics review committee (institutional or regional), the principles outlined in the Declaration of Helsinki (2008) must be followed. For investigations done in humans, the Methods section must state the manner in which informed consent was obtained from the subjects (i.e. oral, or written), and whether participants received a stipend. If experimental animals were used in the research, IJO Press requires that authors confirm adherence to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research in the Methods section of their manuscript.


Conflicts of Interest

A conflict of interest may exist when an author (or the author's institution or employer) has financial, or personal relationships that could inappropriately influence (or bias) the author's decisions, work, or manuscript. All authors are required to disclose potential conflicts of interest in the Acknowledgements section of the manuscript by following the Recommendations of the International Committee of Medical Journal Editors (ICMJE; http://www.icmje.org/urm_main.html). Authors without conflicts of interest, including relevant financial interests, activities, relationships, and affiliations, should indicate that no conflicts of interest exist in the Acknowledgements section of their manuscript. e.g.

Conflicts of Interest: Wang H, None; Barteselli G, None; Freeman WR, None; Lee SN, None; Chhablani J, None; El-Emam S, None; Cheng L, None.

Foundations: All financial support for the research and the work should be clearly and completely identified in an Acknowledgement section of the manuscript.

Clinical Trials: When publishing clinical studies, IJO Press aims to comply with the Recommendations of International Committee of Medical Journal Editors (ICMJE) on trials registration. Therefore, authors are requested to register the clinical trial presented in the manuscript in a public trials registry, and include the trial registration number in the Methods section. The following sites are recognized primary registries by the World Health Organization and the ICMJE.

http://www.anzctr.org.au/ (Australia)

http://www.chictr.org/  (China)

http://www.clinicaltrials.gov (US)

https://www.clinicaltrialsregister.eu  (EU)

http://ctri.nic.in  (India)

http://www.germanctr.de  (Germany)

http://www.ensaiosclinicos.gov.br (Brazil)

http://www.irct.ir  (Iran)

http://isrctn.org  (UK)

http://ncrc.cdc.go.kr (Republic of Korea)

http://registroclinico.sld.cu  (Cuba)

http://www.umin.ac.jp/ctr/index/htm  (Japan)

http://www.trialregister.nl/trialreg/index.asp (the Netherlands)

 

Plagiarism

IJO Press uses Crossref Similarity Check (powered by iThenticate) and AMLC powered by CNKI to screen submitted contents, and we will do some investigation if the software raises any concerns. If plagiarism is detected after manuscript is submitted, the manuscript will be rejected. If plagiarism is detected after publication, we may issue a correction or retraction notice for the related paper. We reserve the right to inform authors' institutions about plagiarism detected either before or after publication. Articles containing plagiarism will be removed from publication and will be reported to the proper authorities.


Publication Policy
According to the IJO Press Publication Policy, only the publication fees are billed per article upon acceptance in order to offset processing charges of articles; the paper reaching the world advanced level will acquire the priority with free publication on IJO and IES. The APC for IER are covered by IJO Press. All of the articles are free to access immediately on IJO Press website from the date of publication. Accepted papers may not be reproduced by any commercial use, in whole or in part, without the written consent of the publisher.

Content License
IJO Press applies the  Creative Commons Attribution (CC BY NC ND) license to works we publish. This license was developed to facilitate open access.
Citation Example
Citation: Bringmann A, Jochmann C, Unterlauft JD, Wiedemann R, Rehak M, Wiedemann P. Different modes of foveal regeneration after closure of full-thickness macular holes by (re)vitrectomy and autologous platelet concentrate. Int J Ophthalmol 2020;13(1):36-48,doi:10.18240/ ijo.2020.01.06

 
Advertising policies

Advertising on web or print journal is the fastest growing medium for product promotion. If you would like to publicize some new research in progress or conference (workshop) information etc. , A publicity service will be available for your information. For more details please send email to ijopress@ 163.com  

Contact us
International Journal of Ophthalmology Press (IJO Press)

Room 11707-08, Building 2, Unit 1, Wanda Plaza, No.8 Yanta North Road, Xi'an 710054, Shaanxi Province, P. R. China

Tel: (+8629)82210956   Fax: (+8629)82245172

Email: ijopress@163.com    ijo2000@126.com  

Website: http://ies.ijo.cn  (Chinese)  www.ijo.cn  (English)